News & Press: Advocacy

SIS Suggests Changes to Premera Blue Cross’ Ablative Treatment for Spinal Pain Policy

Thursday, October 4, 2018  
Share |
On October 3, 2018, SIS submitted comments to Premera Blue Cross regarding their coverage policy, "Ablative Treatments for Occipital Neuralgia, Chronic Headaches, and Atypical Facial Pain." The Society recommends coverage of third occipital nerve (C2-3) radiofrequency neurotomy treatment for headache and occipital neuralgia and provides a detailed summary of the evidence of effectiveness in appropriately selected patients. Click here to read the SIS comment letter.

Contact Us

120 E. Ogden Ave. Ste. 202
Hinsdale, Illinois 60521
P: 630.203.2252
Toll Free: 888.255.0005

© Copyright 2016 Spine Intervention Society Privacy Policy  ::  Legal